Dexloxiglumide, an active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). It is a selective antagonist of cholecystokinin type A (CCKA) receptors.

119817-90-2

C21H30Cl2N2O5

461.38

DMSO:50 mg/mL (108.37 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years